Search for: "ALLERGAN, INC."
Results 161 - 180
of 384
Sort by Relevance
|
Sort by Date
26 Jun 2015, 12:00 pm
Allergan, Inc. 13-1379Issue: Whether, under Buckman Co. v. [read post]
4 Jun 2015, 5:56 am
Allergan, Inc., No. 13-1379. [read post]
3 Jun 2015, 6:16 am
Allergan, Inc., 2015 U.S. [read post]
7 May 2015, 5:00 am
Allergan USA, Inc., 993 F. [read post]
6 May 2015, 6:00 pm
On Monday in California state court, the firm McDermott Will & Emery LLP was accused of legal malpractice and elder abuse by the grandchildren of the founder of pharmaceutical conglomerate Allergan Inc. and their father; claiming the firm helped one... [read post]
19 Apr 2015, 9:56 pm
• Defendants: Allergan, Inc.; Actavis, PLC.; Allergan Sales, LLC Infringement of U.S. [read post]
31 Mar 2015, 9:59 pm
The case involved patentee Senju Pharmaceutical's (joined by Kyorin Pharmaceutical Co. and Allergan, Inc.) suit against Lupin Ltd., Lupin Pharmaceuticals, and Hi-Tech Pharmacal in response to a Paragraph IV certification against Senju's patented ocular antimicrobial agent containing the drug gatifloxacin as claimed in re-examined U.S. [read post]
23 Mar 2015, 5:23 pm
Ct. 831,841 (2015)(claim construction);Allergan, Inc. v. [read post]
21 Mar 2015, 6:26 am
Reference IPR2015-00858.Although this claim survived litigation challenge in Allergan, Inc. v. [read post]
31 Dec 2014, 5:00 am
Wyeth, Inc., 850 N.W.2d 353 (Iowa 2014). [read post]
1 Dec 2014, 6:05 am
On November 17, 2014, Allergan, Inc. announced a $66 billion merger agreement with Actavis plc, thwarting the pending $53 billion bid for Allergan by Valeant Pharmaceuticals International Inc. [read post]
21 Nov 2014, 4:00 am
Allergan’s experts in the 2 cases were the same; Allergan also relied on the evidence of one of the inventors in the Cobalt case1 (whose evidence was not discussed in the decision). [read post]
15 Nov 2014, 9:12 pm
In re Allergan Inc. [read post]
12 Nov 2014, 7:59 am
Allergan, Inc., 2014 U.S. [read post]
10 Nov 2014, 11:10 am
[This story previously appeared in Securities Regulation Daily.]By Anne Sherry, J.D.The Delaware Court of Chancery declined to issue declaratory relief blessing a hypothetical strategy by Allergan stockholders to replace the entire board at a special meeting, as the challenge to Allergan’s interpretation of the “similar item” provision in its governing documents was not ripe for review (In re Allergan, Inc. [read post]
5 Nov 2014, 8:00 am
Valeant Pharmaceuticals Int’l, Inc., Case No. [read post]
5 Nov 2014, 4:06 am
Valeant Pharmaceuticals Int’l, Inc., Case No. [read post]
5 Nov 2014, 4:00 am
Allegan, Inc., 2014 U.S. [read post]
18 Oct 2014, 12:22 pm
Allergan Inc., No. [read post]
8 Oct 2014, 6:29 am
Allergan, Inc. [read post]
